| Effect | Decrease |
| Values | Figure 5 |
| Trial Design | Randomized trial |
| Trial Length | 24 hours |
| Number of Subjects | 40 |
| Sex | Both Genders |
| Age Range | 18-29, 30-44, 45-64, 65+ |
In a randomized trial with unclear blinding, 60 participants with lactase intolerance were given placebo, 9000 units of tilactase, or lactobacillus reuteri with 25 g of lactose. For our purposes, placebo vs. tilactase is the relevant comparison.Funding issues for this study:
The lactase group saw a considerable reduction in breath hydrogen, which was statistically significant compared with the placebo. They also saw substantially larger reductions in bloating, abdominal pain, flatulence, diarrhea.
Unclear funding.
